Timentin

Active Ingredient(s): Ticarcillin + Clavulanic Acid
FDA Approved: * April 1, 1985
Pharm Company: * GLAXOSMITHKLINE
Category: Antibiotics

Ticarcillin/clavulanic acid, or co-ticarclav, is a combination antibiotic consisting of ticarcillin, a β-lactam antibiotic, and clavulanic acid, a β-lactamase inhibitor. This combination results in an antibiotic with an increased spectrum of action and restored efficacy against ticarcillin-resistant bacteria that produce certain β-lactamases.[1] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Timentin Intravenous Injection, Powder, for Solution
NDC: 0029-6571
Labeler:
Glaxosmithkline LLC
Timentin Intravenous Injection, Solution
NDC: 0029-6575
Labeler:
Glaxosmithkline LLC
Timentin Intravenous Injection, Powder, for Solution
NDC: 0029-6579
Labeler:
Glaxosmithkline LLC

Popular Topics

Monitoring Timentin

I'm a home infusion pharmacist . Ortho doctor has asked me to supply any required monitoring parameters/labs/etc dur...